1.
Nicolini FE, Hayette S, Corm S, Bachy E, Bories D, Tulliez M, Guilhot F, Legros L, Maloisel F, Kiladjian J-J, Mahon F-X, LĂȘ Q-H, Michallet M, Roche-Lestienne C, Preudhomme C. Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation. Haematologica 2007; 92(9):1238-1241; https://doi.org/10.3324/haematol.11369.